Center-Authored Papers

Filters: Author is Lane, Dorothy S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2008
Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Pettinger M, Hendrix SL, Hubbell AF, Kooperberg C, Kuller LH, Lane DS et al..  2008.  Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.. American journal of epidemiology. 167(10):1207-16. Abstract
Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Langer RD, Pettinger M, Hendrix SL, Hubbell AF, Kooperberg C, Kuller LH et al..  2008.  Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study.. American journal of epidemiology. 167(12):1407-15. Abstract
2009
Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, Aragaki AK, Ockene JK, Lane DS, Sarto GE et al..  2009.  Breast cancer after use of estrogen plus progestin in postmenopausal women.. The New England journal of medicine. 360(6):573-87. Abstract
Millen AE, Pettinger M, Freudenheim JL, Langer RD, Rosenberg CA, Mossavar-Rahmani Y, Duffy CM, Lane DS, McTiernan A, Kuller LH et al..  2009.  Incident invasive breast cancer, geographic location of residence, and reported average time spent outside.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(2):495-507. Abstract
Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, Jackson RD, Johnson KC, Kuller LH, Lane DS, Wactawski-Wende J et al..  2009.  Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.. American journal of epidemiology. 170(1):12-23. Abstract
Rohan TE, Negassa A, Chlebowski RT, Ceria-Ulep CD, Cochrane BB, Lane DS, Ginsberg M, Wassertheil-Smoller S, Page DL.  2009.  A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease.. Breast cancer research and treatment. 116(2):339-50. Abstract
2010
Chlebowski RT, Chen Z, Cauley JA, Anderson G, Rodabough RJ, McTiernan A, Lane DS, Manson JE, Snetselaar L, Yasmeen S et al..  2010.  Oral bisphosphonate use and breast cancer incidence in postmenopausal women.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(22):3582-90. Abstract
Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE et al..  2010.  Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.. JAMA : the journal of the American Medical Association. 304(15):1684-92. Abstract
2011
Gass MLS, Cochrane BB, Larson JC, Manson JE, Barnabei VM, Brzyski RG, Lane DS, LaValleur J, Ockene JK, Mouton CP et al..  2011.  Patterns and predictors of sexual activity among women in the Hormone Therapy trials of the Women's Health Initiative.. Menopause (New York, N.Y.). 18(11):1160-71. Abstract
Shikany JM, Redden DT, Neuhouser ML, Chlebowski RT, Rohan TE, Simon MS, Liu S, Lane DS, Tinker L.  2011.  Dietary Glycemic Load, Glycemic Index, and Carbohydrate and Risk of Breast Cancer in the Women's Health Initiative.. Nutrition and cancer. 63(6):899-907. Abstract
2012
Kuiper JG, Phipps AI, Neuhouser ML, Chlebowski RT, Thomson CA, Irwin ML, Lane DS, Wactawski-Wende J, Hou L, Jackson RD et al..  2012.  Recreational physical activity, body mass index, and survival in women with colorectal cancer.. Cancer causes & control : CCC. 23(12):1939-48. Abstract
Fugate Woods N, Cochrane BB, LaCroix AZ, Seguin RA, Zaslavsky O, Liu J, Beasley JM, Brunner RL, Espeland MA, Goveas JS et al..  2012.  Toward a Positive Aging Phenotype for Older Women: Observations From the Women's Health Initiative.. The journals of gerontology. Series A, Biological sciences and medical sciences. Abstract
Coghill AE, Phipps AI, Bavry AA, Wactawski-Wende J, Lane DS, Lacroix A, Newcomb PA.  2012.  The Association between NSAID use and Colorectal Cancer Mortality: Results from the Women's Health Initiative.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 21(11):1966-73. Abstract
Simon MS, Rosenberg CA, Rodabough RJ, Greenland P, Ockene I, Roy HK, Lane DS, Cauley JA, Khandekar J.  2012.  Prospective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer risk.. Annals of epidemiology. 22(1):17-27. Abstract
2013
Passarelli MN, Newcomb PA, LaCroix AZ, Lane DS, Ho GYF, Chlebowski RT.  2013.  Oral bisphosphonate use and colorectal cancer incidence in the Women's Health Initiative.. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. Abstract
Chlebowski RT, Manson JE, Anderson GL, Cauley JA, Aragaki AK, Stefanick ML, Lane DS, Johnson KC, Wactawski-Wende J, Chen C et al..  2013.  Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women's Health Initiative Observational Study.. Journal of the National Cancer Institute. 105(8):526-35. Abstract
Kwan K, Chlebowski RT, McTiernan A, Rodabough RJ, Lamonte MJ, Martin LW, Bell C, Lane DS, Kaplan RC, Irwin ML.  2014.  Walking speed, physical activity, and breast cancer in postmenopausal women.. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 23(1):49-52. Abstract
Farhat GN, Parimi N, Chlebowski RT, Manson JE, Anderson G, Huang AJ, Vittinghoff E, Lee JS, LaCroix AZ, Cauley JA et al..  2013.  Sex hormone levels and risk of breast cancer with estrogen plus progestin.. Journal of the National Cancer Institute. 105(19):1496-503. Abstract
2014
Thomson CA, Horn LV, Caan BJ, Aragaki AK, Chlebowski RT, Manson JE, Rohan TE, Tinker LF, Kuller LH, Hou L et al..  2014.  Cancer incidence and mortality during the intervention and postintervention periods of the Women's Health Initiative dietary modification trial.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 23(12):2924-35. Abstract
Bae S, Ulrich CM, Neuhouser ML, Malysheva O, Bailey LB, Xiao L, Brown EC, Cushing-Haugen KL, Zheng Y, Cheng T-YD et al..  2014.  Plasma choline metabolites and colorectal cancer risk in the Women's Health Initiative Observational Study.. Cancer research. 74(24):7442-52. Abstract
Zhao S, Chlebowski RT, Anderson GL, Kuller LH, Manson JE, Gass M, Patterson R, Rohan TE, Lane DS, Beresford SAA et al..  2014.  Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects.. Breast cancer research : BCR. 16(2):R30. Abstract
Brasky TM, Liu J, White E, Peters U, Potter JD, Walter RB, Baik CS, Lane DS, Manson JE, Vitolins MZ et al..  2014.  Non-steroidal Anti-inflammatory Drugs and Cancer Risk in Women: Results from the Women's Health Initiative.. International journal of cancer. Journal international du cancer. Abstract
Thomson CA, McCullough ML, Wertheim BC, Chlebowski RT, Martinez ME, Stefanick ML, Rohan TE, Manson JE, Tindle HA, Ockene J et al..  2014.  Nutrition and Physical Activity Cancer Prevention Guidelines, Cancer Risk, and Mortality in the Women's Health Initiative.. Cancer prevention research (Philadelphia, Pa.). 7(1):42-53. Abstract
Administration, Oral
Chlebowski RT, Chen Z, Cauley JA, Anderson G, Rodabough RJ, McTiernan A, Lane DS, Manson JE, Snetselaar L, Yasmeen S et al..  2010.  Oral bisphosphonate use and breast cancer incidence in postmenopausal women.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(22):3582-90. Abstract
Aged
Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE et al..  2010.  Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.. JAMA : the journal of the American Medical Association. 304(15):1684-92. Abstract